CliffBio
small molecule

LEVOBUNOLOL HYDROCHLORIDE

LEVOBUNOLOL HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVOBUNOLOL HYDROCHLORIDE
Active ingredientLEVOBUNOLOL HYDROCHLORIDE
Strength0.25%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalOctober 1996
Marketing statusDISCN

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LEVOBUNOLOL HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio